Zhou S, Xue XJ, Li RR, Chen DF, Chen WY, Liu GX, Ke EM, Zheng SY. Application of hepatic blood blocker to control bleeding during hepatectomy.
Shijie Huaren Xiaohua Zazhi 2012;
20:790-794. [DOI:
10.11569/wcjd.v20.i9.790]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To compare a new tool named hepatic blood blocker versus the Pringle maneuver and hemihepatic vascular exclusion in controlling bleeding during hepatectomy for liver cancer.
METHODS: The clinical data for 117 patients who underwent hepatectomy for liver cancer from 2004 to 2009 were analyzed retrospectively. Of these patients, 42 underwent local hepatic blood occlusion with hepatic blood blocker (group A), 35 underwent hemihepatic vascular exclusion (group B), and 40 underwent the Pringle maneuver (group C). The blood loss, operative time, postoperative hepatic function and complications were compared among each group.
RESULTS: The average blood loss and operative time were significantly less in group A than in groups B (P < 0.05, 0.001) and C (both P < 0.001). Significant differences were seen between group A and group C in serum total bilirubin (TB) and alanine transaminase (ALT) on postoperative days 3 and day 7, and group A showed better hepatic function (TB: P = 0.014, 0.009; ALT: both P < 0.001). The Pringle maneuver significantly increased the rate of postoperative abdominal dropsy when compared to group A (P < 0.001). In group C, two patients suffered from liver failure, one suffered from alimentary tract hemorrhage and one died.
CONCLUSION: Using hepatic blood blocker during hepatectomy could effectively control bleeding, reduce operative time and preserve hepatic function, representing a safe and feasible technique.
Collapse